Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Management of acute metastatic melanoma

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK

Management of acute metastatic melanoma ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )

How should we handle talimogene laherparepvec (T-VEC)?

Prof Axel Hauschild - University of Kiel, Kiel, Germany

How should we handle talimogene laherparepvec (T-VEC)? ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

Editor's choice for October 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

Editor's choice for October 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Targeting N-RAS mutated tumours

Prof Axel Hauschild - University of Kiel, Kiel, Germany

Targeting N-RAS mutated tumours ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma

Prof Axel Hauschild - University of Kiel, Kiel, Germany

Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

System reform needed for UK medicine approval

Paul Catchpole - Value and Access Director, The Association of the British...

System reform needed for UK medicine approval ( Paul Catchpole - Value and Access Director, The Association of the British Pharmaceutical Industry )

How should decision makers assess the value of a medicine?

Dr Hans-Georg Eichler - Senior Medical Officer, European Medicines Agency

How should decision makers assess the value of a medicine? ( Dr Hans-Georg Eichler - Senior Medical Officer, European Medicines Agency )

Systemic immunotherapy and radiotherapy combination shows promise in advanced...

Dr Susan Hiniker - Stanford University, Stanford, USA

Systemic immunotherapy and radiotherapy combination shows promise in advanced skin cancer ( Dr Susan Hiniker - Stanford University, Stanford, USA )

Is 3D-conformational or intensity-modulated radiation therapy better for NSCLC?

Dr Stephen Chun - MD Anderson Cancer Centre, Houston, USA

Is 3D-conformational or intensity-modulated radiation therapy better for NSCLC? ( Dr Stephen Chun - MD Anderson Cancer Centre, Houston, USA )

Can early stage NSCLC be treated with stereotactic radiation therapy?

Dr David Palma – London Health Sciences Centre, London, Canada

Can early stage NSCLC be treated with stereotactic radiation therapy? ( Dr David Palma – London Health Sciences Centre, London, Canada )

Treatment strategies and options in castration-resistant and advanced prostate...

Prof Peter Mulders, Prof Luis Costa, Prof Antonio Alcaraz, Prof Anwar Padhani

Treatment strategies and options in castration-resistant and advanced prostate cancer ( Prof Peter Mulders, Prof Luis Costa, Prof Antonio Alcaraz, Prof Anwar Padhani )

What are the obstacles in cancer prevention?

Prof Jack Cuzick - Queen Mary University of London, London, UK

What are the obstacles in cancer prevention? ( Prof Jack Cuzick - Queen Mary University of London, London, UK )

More from ecancer